These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 1980062)
1. Molecular mechanisms of drug resistance. Hayes JD; Wolf CR Biochem J; 1990 Dec; 272(2):281-95. PubMed ID: 1980062 [No Abstract] [Full Text] [Related]
2. Multidrug resistance genes, p-glycoprotein and the liver. Arias IM Hepatology; 1990 Jul; 12(1):159-65. PubMed ID: 1973680 [No Abstract] [Full Text] [Related]
3. Drug resistance dependent on different molecular size P-glycoproteins in Yoshida rat ascites hepatoma cells. Miyamoto K; Wakusawa S; Nakamura S Biochem Pharmacol; 1992 Mar; 43(5):1143-5. PubMed ID: 1348175 [No Abstract] [Full Text] [Related]
4. Molecular analysis of the multidrug transporter. Germann UA Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331 [TBL] [Abstract][Full Text] [Related]
6. Charles F. Kettering Prize. P-glycoprotein and resistance to anticancer drugs. Ling V Cancer; 1992 May; 69(10):2603-9. PubMed ID: 1348966 [No Abstract] [Full Text] [Related]
7. P glycoprotein (P-gp) and drug resistance--time for reappraisal? Kaye SB Br J Cancer; 1993 Apr; 67(4):641-3. PubMed ID: 8097103 [No Abstract] [Full Text] [Related]
9. Is the multidrug transporter a flippase? Higgins CF; Gottesman MM Trends Biochem Sci; 1992 Jan; 17(1):18-21. PubMed ID: 1374941 [TBL] [Abstract][Full Text] [Related]
10. The intriguing link between modulation of both multidrug resistance and ligand-toxin conjugate cytotoxicity. Jaffrézou JP; Laurent G FEBS Lett; 1993 Jun; 323(3):191-7. PubMed ID: 8099019 [TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance: molecular biology and clinical relevance. Rothenberg M; Ling V J Natl Cancer Inst; 1989 Jun; 81(12):907-10. PubMed ID: 2567355 [No Abstract] [Full Text] [Related]
13. Modelling the process of drug resistance. Goldie JH Lung Cancer; 1994 Mar; 10 Suppl 1():S91-6. PubMed ID: 7916254 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Pilarski LM; Cass CE; Tsuro T; Belch AR Curr Top Microbiol Immunol; 1992; 182():177-85. PubMed ID: 1362698 [No Abstract] [Full Text] [Related]
16. Multidrug resistance: clinical findings and implications. Friedlander ML; Bell DR Cancer Treat Res; 1989; 42():63-77. PubMed ID: 2577108 [No Abstract] [Full Text] [Related]
17. Conquering multidrug resistance in cancer chemotherapy. Edgington SM Biotechnology (N Y); 1992 Mar; 10(3):269-70. PubMed ID: 1369474 [No Abstract] [Full Text] [Related]
18. Selective growth-inhibition of multidrug-resistant CHO-cells by the monoclonal antibody 265/F4. Efferth T; Lathan B; Volm M Br J Cancer; 1991 Jul; 64(1):87-9. PubMed ID: 1677260 [No Abstract] [Full Text] [Related]
19. Multidrug resistance: P-glycoprotein and its allies--the elusive foes. Chabner BA; Fojo A J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356 [No Abstract] [Full Text] [Related]
20. A mathematical model for the inhibition of the multidrug resistance-associated P-glycoprotein pump. Michelson S; Slate D Bull Math Biol; 1994 Mar; 56(2):207-23. PubMed ID: 7910503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]